Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 10 mg in Japanese Healthy Male Adult Subjects
Clinical trial NCT04511611 · COMPLETED
Trial details
- NCT number
- NCT04511611
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2019-03-27
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.